Artemis medicare services Limited has submitted its mandatory compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The healthcare services company filed the certificate with both the National Stock Exchange of India Limited and BSE Limited on April 6, 2026.

Regulatory Filing Details

The compliance certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Poonam Makkar signed the filing on behalf of Artemis Medicare Services Limited.

Registrar Confirmation

Alankit Assignments Limited, serving as the registrar and transfer agent, provided the compliance certificate confirming proper handling of dematerialization processes. Kamal Garg, General Manager at Alankit Assignments Limited, digitally signed the certificate on April 6, 2026.

The registrar confirmed that securities comprised in physical share certificates received for dematerialization have been properly processed. The certificate states that after due verification, physical certificates were mutilated and cancelled, with the depository name being substituted in records as the registered owner.

Compliance Framework

The filing demonstrates Artemis Medicare Services Limited's adherence to SEBI's regulatory framework governing depositories and participants. The quarterly compliance certificate ensures transparency in the dematerialization process and maintains investor confidence in the electronic settlement system.

Alankit Assignments Limited holds multiple SEBI registrations and operates from its registered office in New Delhi, providing comprehensive registrar and transfer agent services to listed companies.

Artemis Medicare Services Limited has announced its participation in an upcoming investor conference, as disclosed to stock exchanges on March 17, 2026. The company has informed both NSE and BSE about the scheduled event in compliance with regulatory requirements.

Conference Details

The healthcare company will participate in the Hospitals & Diagnostics Conference, providing an opportunity for direct interaction with analysts and institutional investors. The event details are structured as follows:

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions.

Important Considerations

Artemis Medicare Services Limited has noted that the conference schedule may be subject to changes in case of exigencies from analysts, investors, or the company itself. This flexibility clause ensures that unforeseen circumstances can be accommodated while maintaining transparency with stakeholders.

Company Communication

The disclosure was signed by Poonam Makkar, Company Secretary and Compliance Officer, emphasizing the company's commitment to maintaining proper corporate governance standards. The communication was simultaneously sent to both major Indian stock exchanges where the company's shares are listed.

This investor conference represents part of Artemis Medicare Services Limited's ongoing engagement strategy with the investment community, providing a platform for discussing the company's performance and future prospects in the healthcare sector.